FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071727 [Registered on: 31/07/2024] Trial Registered Prospectively
Last Modified On: 22/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   ashwattha pallava churna in medoroga with special referance to dyslipidemia 
Scientific Title of Study   A randomized open labelled single arm clinical study of Ashwattha pallava churna in Medoroga with special reference to Dyslipidemia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sahil Bhavsar 
Designation  PG Scholar 
Affiliation  Taranath Government Ayurvedic Medical College 
Address  Department of PG studies in Dravyaguna, Taranath Government Ayurvedic Medical College, Ballari, Karnataka

Bellary
KARNATAKA
583101
India 
Phone  9898417304  
Fax    
Email  shbhavsar16698@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rajashekhar Ganiger 
Designation  HOD 
Affiliation  Taranath Government Ayurvedic medical College and Hospital 
Address  Department of PG studies in Dravyaguna, Taranath Government Ayurvedic Medical College, Ballari, Karnataka

Bellary
KARNATAKA
583101
India 
Phone  9448234194  
Fax    
Email  rsganiger@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Madhav Diggavi 
Designation  HOD 
Affiliation  Taranath Government Ayurvedic medical College and Hospital 
Address  Department of PG studies in Kayachikitsa, Taranath Government Ayurvedic Medical College, Ballari, Karnataka

Bellary
KARNATAKA
583101
India 
Phone  9844094290  
Fax    
Email  drmvdbly@gmail.com  
 
Source of Monetary or Material Support  
Department of Dravyaguna Taranath government ayurvedic medical college and hospital Ballari Karnataka India 583101 
 
Primary Sponsor  
Name  Dr. Sahil Bhavsar 
Address  Department of Dravyaguna, Taranath Government Ayurvedic Medical College, Ballari, Karnataka 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sahil Bhavsar  Taranath Government Ayurvedic Medical College and Hospital  Room no 1 Kayachikitsa OPD Department Taranath Government Ayurvedic Medical College and Hospital Dr rajkumar road
Bellary
KARNATAKA 
9898417304

shbhavsar16698@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee of Taranath Govt. Ayurvedic Medical College Ballari  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E788||Other disorders of lipoprotein metabolism. Ayurveda Condition: MEDOROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Ashwattha pallava, Reference: Yogratnakara Purvardha Raktapitta chikitsa adhyaya 50th shloka, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Antarabhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: Madhu), Additional Information:
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1)BMI between 25 to 38.9 kg/m2 .
2)Dyslipidemia associated disorders like Non-insulin dependent diabetes mellitus [NIDDM]- RBS up to 200 mg/dl.
Coronary artery disease [CAD]
P/H/O myocardial infarction Hypertension
B.P. up to 160/100 mmHg
 
 
ExclusionCriteria 
Details  1)Patients with HIV, HbsAg or any infective disorders
2) Patients undergone cardiac surgeries like coronary artery bypass graft [CABG], angioplasty, open heart surgery etc.
3)BMI less than 24 kg/m2 and more than 39 kg/m2 .
4)Chronic severe disorders like Chronic renal failure. Severe type 2 diabetes mellitus- RBS more than 200mg/dl. Severe hypertension – more than 160/100 mmHg.
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Lipid profile  3 months 
 
Secondary Outcome  
Outcome  TimePoints 
All outcomes which effect the quality of life.  6 months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   20/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="5"
Days="29" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is randomized, open labelled, single arm clinical study evaluating the safety and efficacy of Ashwattha Pallava Churna (Ficus religiosa Linn.) 5 gm BID for 60 days in 40 randomly selected patients from the hospital of Taranath Goverrnment Ayurvedic Medical College and Hospital Ballari, Karnataka. 
Close